PT  - JOURNAL ARTICLE
AU  - Xiao, Minglu
AU  - Xie, Luoyingzi
AU  - Cao, Guoshuai
AU  - Lei, Shun
AU  - Wang, Pengcheng
AU  - Wei, Zhengping
AU  - Luo, Yuan
AU  - Fang, Jingyi
AU  - Yang, Xingxing
AU  - Huang, Qizhao
AU  - Xu, Lifan
AU  - Guo, Junyi
AU  - Wen, Shuqiong
AU  - Wang, Zhiming
AU  - Wu, Qing
AU  - Tang, Jianfang
AU  - Wang, Lisha
AU  - Chen, Xiangyu
AU  - Chen, Cheng
AU  - Zhang, Yanyan
AU  - Yao, Wei
AU  - Ye, Jianqiang
AU  - He, Ran
AU  - Huang, Jun
AU  - Ye, Lilin
TI  - CD4<sup>+</sup> T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
AID  - 10.1136/jitc-2021-004022
DP  - 2022 May 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004022
VI  - 10
IP  - 5
4099  - http://jitc.bmj.com/content/10/5/e004022.short
4100  - http://jitc.bmj.com/content/10/5/e004022.full
SO  - J Immunother Cancer2022 May 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.